Is Narayana Hrudayalaya a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Narayana Hrudayalaya Ltd is a good quality company .

Is Narayana Hrudayalaya undervalued or overvalued?

The key valuation ratios of Narayana Hrudayalaya Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Narayana Hrudayalaya share price return in the past 10 years?

Data is not available for this company

Is Narayana Hrudayalaya a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Narayana Hrudayalaya Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Narayana Hrudayalaya?

The latest standalone P/E ratio of Narayana Hrudayalaya as of 11-Dec-2024 is 61.02.

What is the P/B ratio of Narayana Hrudayalaya?

The latest standalone P/B ratio of Narayana Hrudayalaya as of 11-Dec-2024 is 13.43.

Narayana Hrudayalaya Ltd - Stock Valuation and Financial Performance

Name: Narayana Hrudayalaya
Brand: Narayana Hrudayalaya

BSE: 539551 | NSE: NH | Hospital & Healthcare Services | Small Cap

Place order

Narayana Hrudayalay Share Price

₹1,280 -8.40 -0.65%
as on 11-Dec'24 16:59

10 Year X-Ray of Narayana Hrudayalay:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	6.4%	7.5%	14.1%	8.9%	9.3%	13.6%	1.5%	26.8%	33.9%	27.7%	-
Value Creation Index ⓘ	-0.4	-0.5	0.0	-0.3	-0.3	0.0	-0.9	1.0	1.5	1.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1,364	1,614	1,878	2,281	2,861	3,128	2,583	3,701	4,525	5,018	5,224
Sales YoY Gr.	-	18.3%	16.4%	21.4%	25.4%	9.3%	-17.4%	43.3%	22.3%	10.9%	-
Adj EPS ⓘ	-0.8	1.5	4.2	2.6	2.8	5.8	-0.5	17	29.7	38.5	38.1
YoY Gr.	-	NA	182.3%	-37.6%	8.9%	106.7%	-108.2%	NA	74.5%	30%	-
BVPS (₹) ⓘ	38.4	42.7	46.7	50	52.8	55.4	54.6	72.7	104.3	141.1	156.9
Adj Net Profit ⓘ	-16	30	84.8	52.9	57.7	119	-9.9	347	606	788	779
Cash Flow from Ops. ⓘ	76.7	174	219	182	279	443	304	485	1,085	1,067	-
Debt/CF from Ops. ⓘ	4.7	1.5	1	4.4	2.9	1.6	2	1.1	0.7	1.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	15.6%	11.9%	24.8%	10.9%
Adj EPS ⓘ	NA	68.7%	NA	30%
BVPSⓘ	15.6%	21.7%	37.2%	35.3%
Share Price	-	33.2%	30.5%	9.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-2.4	3.6	9.2	5.3	5.5	10.7	-0.9	26.6	33.5	31.4	25.6
Op. Profit Mgn % ⓘ	9.4	11.1	12.3	9.8	10.3	13.9	7.6	18.2	21.8	23.4	22.7
Net Profit Mgn % ⓘ	0.5	1.8	4.5	2.3	2	3.8	-0.4	9.4	13.4	15.7	14.9
Debt to Equity ⓘ	0.5	0.3	0.2	0.8	0.8	0.6	0.6	0.4	0.4	0.5	0.4
Working Cap Days ⓘ	90	81	72	79	78	70	79	65	69	77	67
Cash Conv. Cycle ⓘ	5	4	-4	-3	-3	-9	-14	-13	-17	-22	26

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 24.78%

Return on Equity has declined versus last 3 years average to 25.60%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 6.85%

Latest Financials - Narayana Hrudayalaya Ltd.

	Standalone	Consolidated
TTM EPS (₹)	21	38.1
TTM Sales (₹ Cr.)	3,423	5,224
BVPS (₹.) ⓘ	95.3	156.9
Reserves (₹ Cr.) ⓘ	1,828	3,001
P/BV ⓘ	13.43	8.16
PE ⓘ	61.02	33.59

From the Market
52 Week Low / High (₹)	1087.80 / 1445.05
All Time Low / High (₹)	181.35 / 1445.05
Market Cap (₹ Cr.)	26,158
Equity (₹ Cr.)	204.4
Face Value (₹)	10
Industry PE ⓘ	43.9

Management X-Ray of Narayana Hrudayalay:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Narayana Hrudayalay

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Narayana Hrudayalay

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	1,364	1,614	1,878	2,281	2,861	3,128	2,583	3,701	4,525	5,018
Operating Expenses ⓘ	1,238	1,437	1,649	2,061	2,566	2,701	2,394	3,038	3,544	3,851
Manufacturing Costs	463	534	625	776	929	988	862	1,080	1,287	1,400
Material Costs	341	387	436	557	688	745	678	909	1,001	1,074
Employee Cost	277	334	375	466	623	674	627	768	879	1,004
Other Costs ⓘ	158	182	213	263	327	294	227	280	377	372
Operating Profit ⓘ	126	177	229	220	295	427	189	663	980	1,167
Operating Profit Margin (%)	9.2%	11.0%	12.2%	9.6%	10.3%	13.6%	7.3%	17.9%	21.7%	23.3%
Other Income ⓘ	8	16	23	19	19	28	27	35	65	75
Interest ⓘ	45	33	28	55	81	94	82	76	84	112
Depreciation ⓘ	68	76	80	100	137	186	184	183	210	242
Exceptional Items ⓘ	0	-11	-1	1	0	-11	0	0	0	0
Profit Before Tax ⓘ	21	51	135	80	93	161	-56	430	752	889
Tax ⓘ	15	30	52	29	34	42	-42	88	145	99
Profit After Tax	6	21	83	51	59	119	-14	342	607	790
PAT Margin (%)	0.4%	1.3%	4.4%	2.3%	2.1%	3.8%	-0.6%	9.2%	13.4%	15.7%
Adjusted EPS (₹)	-0.8	1.0	4.1	2.5	2.9	5.8	-0.7	16.7	29.7	38.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	35%	17%	0%	6%	8%	10%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	768	873	954	1,022	1,079	1,133	1,117	1,485	2,131	2,884
Share Capital ⓘ	200	204	204	204	204	204	204	204	204	204
Reserves ⓘ	568	668	749	818	874	928	912	1,281	1,926	2,679
Minority Interest	1	0	0	0	0	1	1	1	1	1
Debt	305	232	189	734	737	629	525	444	639	1,220
Long Term Debt	207	188	180	696	725	619	504	432	626	1,195
Short Term Debt	99	45	9	38	12	11	21	11	13	25
Trade Payables	136	161	207	305	334	362	410	449	615	604
Others Liabilities ⓘ	160	290	297	466	484	765	715	754	772	911
Total Liabilities ⓘ	1,370	1,556	1,647	2,528	2,633	2,889	2,768	3,133	4,157	5,619
Fixed Assets
Gross Block	1,220	1,417	1,522	2,385	2,504	2,943	2,982	3,155	3,671	4,137
Accumulated Depreciation	307	363	440	537	666	851	1,022	1,175	1,334	1,486
Net Fixed Assetsⓘ	913	1,055	1,082	1,848	1,838	2,092	1,961	1,980	2,336	2,651
CWIP ⓘ	20	14	53	35	56	12	20	67	259	514
Investmentsⓘ	52	87	96	9	17	86	120	132	252	844
Inventories	51	50	52	84	83	60	48	59	72	110
Trade Receivables	143	152	157	279	266	262	279	437	432	422
Cash Equivalents	30	24	34	35	101	115	132	172	380	416
Others Assetsⓘ	161	175	173	238	271	262	209	285	427	662
Total Assets ⓘ	1,370	1,556	1,647	2,528	2,633	2,889	2,768	3,133	4,157	5,619

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	77	174	219	182	279	443	304	485	1,085	1,067
PBT ⓘ	21	51	135	80	93	161	-56	430	752	889
Adjustment ⓘ	111	136	112	162	231	295	250	274	313	285
Changes in Working Capital ⓘ	-32	22	8	-27	8	53	56	-152	105	-15
Tax Paid ⓘ	-22	-35	-37	-34	-54	-66	54	-67	-86	-91
Cash Flow From Investing Activity ⓘ	-222	-150	-146	-534	-161	-189	-113	-267	-1,174	-1,458
Capex	-92	-90	-119	-203	-150	-114	-70	-250	-521	-968
Net Investments	-4	-3	-19	-174	-12	-75	-51	-18	-417	-509
Others ⓘ	-126	-57	-9	-157	1	1	8	1	-236	18
Cash Flow From Financing Activityⓘ	140	18	-45	315	-27	-247	-194	-159	88	488
Net Proceeds from Shares ⓘ	200	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-158	49	-5	347	28	-108	-102	-68	208	368
Interest Paid ⓘ	-39	-25	-21	-32	-55	-51	-43	-36	-43	-73
Dividend Paid ⓘ	0	0	0	0	0	-49	0	0	-20	-51
Others ⓘ	137	-6	-20	0	0	-39	-48	-55	-57	244
Net Cash Flow ⓘ	-5	42	28	-36	90	8	-2	59	-2	97

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	0.88	2.54	9.09	5.2	5.64	10.77	-1.27	26.3	33.55	31.5
ROCE (%)	6.36	7.45	14.09	8.94	9.34	13.61	1.46	26.83	33.92	27.71
Asset Turnover Ratio	1.08	1.1	1.17	1.09	1.11	1.13	0.91	1.25	1.24	1.03
PAT to CFO Conversion(x)	12.83	8.29	2.64	3.57	4.73	3.72	N/A	1.42	1.79	1.35
Working Capital Days
Receivable Days	37	33	30	35	35	31	38	35	35	31
Inventory Days	13	11	10	11	11	8	8	5	5	7
Payable Days	155	140	154	168	169	170	208	172	194	207

Narayana Hrudayalaya Ltd Stock News

Narayana Hrudayalaya Ltd FAQs

What is the share price of Narayana Hrudayalay?

Company share prices are keep on changing according to the market conditions. The closing price of Narayana Hrudayalay on 11-Dec-2024 16:59 is ₹1,280.

What is the market cap of Narayana Hrudayalay?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Dec-2024 16:59 the market cap of Narayana Hrudayalay stood at ₹26,158.2.

What is the P/E ratio of Narayana Hrudayalay?

The latest P/E ratio of Narayana Hrudayalay as of 11-Dec-2024 16:59 is 61.02.

What is the P/B ratio of Narayana Hrudayalay?

The latest P/B ratio of Narayana Hrudayalay as of 11-Dec-2024 16:59 is 13.43.

What is the 52-week high and low of Narayana Hrudayalay?

The 52-week high of Narayana Hrudayalay is ₹1,445.1 and the 52-week low is ₹1,087.8.

What is the TTM revenue of Narayana Hrudayalay?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Narayana Hrudayalay is ₹3,423 ( Cr.) .

About Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited was incorporated on July 19, 2000 under the Companies Act, 1956. The Company, headquartered in Bengaluru is engaged in providing economical healthcare services. The Company was rebranded as ‘Narayana Health’ in 2013. It has a network of multispecialty and superspeciality hospitals spread across multiple locations.

The company was founded by its Promoter Devi Prasad Shetty, who has over 30 years of medical experience, including as a cardiac surgeon. The company is headquartered in Bengaluru, India, and operates a national network of hospitals in India with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in western and central India. The company’s ‘Narayana Health’ brand is strongly associated with its mission to deliver high quality and affordable healthcare services to the broader population by leveraging its economies of scale, skilled doctors, and an efficient business model.

Business area of the company

The company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals.

Products and Services

Anaesthesia & Critical Care
Blood Bank
Bone Marrow Transplant
Breast Cancer
Cardiac Surgery - Adult
Cardiology - Adult
Clinical Nutrition & Dietetics
Cranio-Maxillo Facial Surgery
Dental Sciences
Dermatology and Cosmetology
Developmental Medicine
Diabetology
E.N.T
Electrophysiology
Emergency Medicine
Endocrinology
Family Medicine
Gastroenterology - Medical
Gastroenterology - Surgical
Gastrointestinal Oncology
General Surgery
Genetics
Geriatrics
Gynaecology - Oncology
Haemato Oncology
Haematology
Head & Neck Surgery - Oncology
Heart Transplant
Infectious Diseases
Integrative Oncology
Internal Medicine
Interventional Radiology
Kidney Transplant - Adult
Lab
Liver Transplant & HPB Surgery
Medical Oncology
Microbiology
Nephrology
Neurology
Neurosurgery
NICU & PICU
Nuclear Medicine
Obstetrics & Gynaecology
Oncology
Ophthalmology
Ortho - Oncology
Orthopaedics
Pain & Palliation - Oncology
Pathology
Physical Medicine and Rehabilitation
Physiotherapy & Rehabilitation
Plastic Surgery
Psychiatry & Clinical Psychology
Pulmonology
Radiation Oncology
Radiology
Reproductive Medicine
Rheumatology
Robotic Surgery
Speech And Swallow Rehabilitation
Spine Surgery
Surgical Oncology
Thoracic Surgery
Uro - Oncology
Urology
Vascular Surgery

Awards

2010:

Awarded as the Best Single Speciality Hospital - Cardiology at 'India Healthcare Awards 2010'

2011:

A proud recipient of the “India Shining Star CSR Award' for the exceptional CSR work in the health sector

2012:

FICCI Health Care Excellence Award
Frost and Sullivan India Healthcare Excellence Awards

2013:

Financial Times Arcelor Mittal Boldness in Business Awards
Inc. India Innovative 100 Award

2014:

Narayana health was recognised among world’s top 50 ‘BCG Local Dynamos 2014’ for its exceptional operational efforts.
Gold Award winner in Customer Service by Asian Hospital Management Awards
Winner of ABP News Brand Excellence Award 2014

2015:

Identified for its exceptional work in the department of cardiology, NICS has been named the Best Single Specialty Hospital in India, Cardiology in the CNBC TV 18 & ICICI Lombard India Healthcare Award 2015-16
Recognized for its technology enabled innovative primary healthcare services to people living in resource deprived locations in India, Narayana Health has been awarded Public Health Champion Award by WHO India under the category of Innovation
NH receives the Healthcare Leadership Awards by Stars of the Industry Group in 2 categories; Outstanding Achievement Awards Healthcare - Social Cause, Healthcare & Social Care Support Award

2016:

Health Brand of the Year - Healthcare - India Health & Wellness Awards
Quality beyond Accreditation for NH Jaipur at the Global Conclave of Association of Health Care Providers India (AHPI)

2017:

Narayana Health was recognized as one of the Best Asian Healthcare Brands by the Economic Times, for its immense contributions & unique initiatives to improve the healthcare industry.
Best Cardiac Science Institute of the Year
Narayana Superspeciality Hospital Howrah was recognized as the Best Superspeciality Hospital of the Year (Oncology) at the International Healthcare Awards 2017 - country's most authoritative Summit & Awards for the healthcare industry.

2018:

Narayana Health won the Silver in Reproductive and Sexual Health Category at India Health & Wellness Summit and Awards.
Narayana Health listed in Fortune India 500
CSR Excellence in Healthcare

Milestones

2000: Commenced operations from NICS in Bengaluru
2008: The company entered into an investment agreement with the investor Selling Shareholders for the purpose of subscription by the investor Selling Shareholders to 75,414 Equity Shares of Rs 10 each of the company (in the aggregate) for a purchase price of Rs 53,040.55 (approximately) per share, including share premium of Rs 53,030.55 (approximately) per share.
2014: Acquired AHDL.
2014: Acquired the Jubilant Kalpataru Hospital, Barasat, West Bengal.
2014: The company entered into a securities subscription agreement with CDC Group and CDC IOL for subscription to its equity shares and OCDs aggregating to around Rs 300 crore.
2015: Obtained JCI accreditation for HCCI's multispecialty hospital in Cayman Islands.
2018: Narayana Health City Launches ‘Senior Citizen’s Privilege Card’
2018: Narayana Superspeciality Hospital empaneled with CGHS & NHPC
2019: Narayana Health Guwahati opens Day care dialysis center.
2019: Narayana Multispeciality Hospital Launches A Comprehensive Weight Loss Clinic : 1st In Mysore
2019-20: SRCC Children’s Hospital, Mumbai completed 1,000 paediatric cardiac surgeries since its inception strengthening facility’s position as a top-notch medical destination for paediatric treatment
2019-20: Foundation stone laid for setting up a comprehensive Radiation Centre at Health City Cayman Islands
2019-20: Company signed a 3-year contract to deploy and manage NH’s Proprietary Data Intelligence Platform - MEDHA for a PanIndia Hospital Group